Menu
We’re thrilled to share the latest publication from our Working Group 3 (WG3) at IMMUPARKNET COST Action 21117, published in npj Parkinson’s Disease! Entitled “Recommendations...
We invite you to a stimulating discussion on May 15, 2025, at 3:00 PM CET, organized as part of the COST Action CA21117. This online...
On the last day of April 2025, we recap the Annual Meeting of IMMUPARKNET COST Action that took place at NOVA Medical School (NMS), in...
We invite you to a stimulating discussion on January 23, 2025, at 3:00 PM CET, organized as part of the COST Action CA21117. This online...
COST (European Cooperation in
Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
The Action focuses on Parkinson’s disease (PD) challenges and aims at establishing an innovative, multi-interdisciplinary Network, fostering the exchange of expertise among outstanding experts, from different countries and institutions, involving scientists studying immunity in PD but also immunity in other neurodegenerative diseases.
MoU – 031/22
CSO Approval date – 27/05/2022
Start date – 20/09/2022
End date – 19/09/2026
Design by Boutik
